Retatrutide Shows Promising Results in Phase 3 Weight Loss Trial | Retatrutide News

Retatrutide achieved up to 30.3% average weight loss in the Phase 3 TRIUMPH-1 trial. This highlights its potential as a promising treatment option in th...
Clinical Trials · October 10, 2026